(Q36820909)

16 August 2017

C5a is not involved in experimental autoimmune myasthenia gravis pathogenesis (English)

1 reference

16 August 2017

0 references

Huibin Qi

1

1 reference

16 August 2017

Erdem Tüzün

2

1 reference

16 August 2017

Windy Allman

3

1 reference

16 August 2017

Shamsher S Saini

4

1 reference

16 August 2017

Zurina R Penabad

5

1 reference

16 August 2017

Silvia Pierangeli

6

1 reference

16 August 2017

Premkumar Christadoss

7

1 reference

16 August 2017

1 May 2008

1 reference

Journal of Neuroimmunology

16 August 2017

1 reference

16 August 2017

196

1 reference

16 August 2017

1-2

1 reference

16 August 2017

101-106

1 reference

Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status.

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645869

Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645869

The C5a complement activation peptide increases IL-1beta and IL-6 release from amyloid-beta primed human monocytes: implications for Alzheimer's disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645869

rC5a directs the in vitro migration of human memory and naive tonsillar B lymphocytes: implications for B cell trafficking in secondary lymphoid tissues

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645869

Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645869

C5a and Fcgamma receptors: a mutual admiration society

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645869

IL-1 receptor antagonist-mediated therapeutic effect in murine myasthenia gravis is associated with suppressed serum proinflammatory cytokines, C3, and anti-acetylcholine receptor IgG1.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645869

Inhibition of acute passive transfer experimental autoimmune myasthenia gravis with Fab antibody to complement C6.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645869

C5a receptor-deficient mice are protected from thrombophilia and endothelial cell activation induced by some antiphospholipid antibodies.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645869

C5a receptor deficiency attenuates T cell function and renal disease in MRLlpr mice.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645869

Genetic Evidence for Involvement of Classical Complement Pathway in Induction of Experimental Autoimmune Myasthenia Gravis

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645869

Identification and characterization of the effector region within human C5a responsible for stimulation of IL-6 synthesis

5 September 2018

1 reference

12 December 2020

Diagnostic significance of IgG, C3, and C9 at the limb muscle motor end-plate in minimal myasthenia gravis

1 reference

12 December 2020

Genetic evidence for the involvement of Fcgamma receptor III in experimental autoimmune myasthenia gravis pathogenesis

1 reference

12 December 2020

Natural killer cells determine the outcome of B cell–mediated autoimmunity

1 reference

12 December 2020

1 reference

12 December 2020

Immunotherapy for myasthenia gravis: a murine model

1 reference

12 December 2020

C5 gene influences the development of murine myasthenia gravis

1 reference

12 December 2020

10.1016/J.JNEUROIM.2008.03.007

Identifiers

DOI

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

18455242

1 reference